Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: The Multiethnic Cohort

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Haiman, Christopher A ^a   Garcia, Rachel R ^a   Hsu, Chris ^a   Xia, Lucy ^a   Ha, Helen ^b   Sheng, Xin ^a   Le Marchand, Loic ^c   Kolonel, Laurence N ^c   Henderson, Brian E ^a   Stallcup, Michael R ^a   Greene, Geoffrey L ^d   Press, Michael F ^e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRG1 PROTEIN; BRM PROTEIN; CALCIUM BINDING AND COILED COIL DOMAIN 1; COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN D1; E1A ASSOCIATED P300 PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HORMONE RECEPTOR; N METHYLPURINE DNA GLYCOSYLASE; NON METASTATIC CELL 1 PROTEIN; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR COREPRESSOR; NUCLEAR RECEPTOR COREPRESSOR 1; PROTEIN ARGININE METHYLTRANSFERASE; REGULATOR PROTEIN; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TUMOR MARKER; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DNA MODIFICATION; DNA SEQUENCE; ETHNIC DIFFERENCE; EXON; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; AFRICAN AMERICAN; AGED; ALLELE; ASIAN AMERICAN; BREAST TUMOR; CAUCASIAN; COHORT ANALYSIS; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; HISPANIC; MIDDLE AGED; RISK; UNITED STATES;

AFRICAN AMERICANS; AGED; ALLELES; ASIAN AMERICANS; BREAST NEOPLASMS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; HAWAII; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 60549110715     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-43     Document Type: Article

References (52)

1. Henderson BE Ross RK Pike MC Casagrande JT Endogenous hormones as a major factor in human cancer Cancer Res 1982, 42(8):3232-3239 7046921
2. Key T Appleby P Barnes I Reeves G Endogenous sex hormones and breast cancer in postmenopausal women: Reanalysis of nine prospective studies J Natl Cancer Inst 2002, 94(8): 606-616 11959894
3. Pike MC Spicer DV Dahmoush L Press MF Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk Epidemiol Rev 1993, 15(1):17-35 8405201
4. Henderson BE Feigelson HS Hormonal carcinogenesis Carcinogenesis 2000, 21(3):427-433 10.1093/carcin/21.3.427 10688862
5. Pike MC Krailo MD Henderson BE Casagrande JT Hoel DG 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer Nature 1983, 303(5920):767-770 10.1038/303767a0 6866078
6. Haiman CA Hankinson SE Spiegelman D Colditz GA Willett WC Speizer FE Kelsey KT Hunter DJ The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer Cancer Res 1999, 59(5):1015-1020 10070957
7. Hunter DJ Riboli E Haiman CA Albanes D Altshuler D Chanock SJ Haynes RB Henderson BE Kaaks R Stram DO et al A candidate gene approach to searching for low-penetrance breast and prostate cancer genes Nat Rev Cancer 2005, 5(12):977-985 10.1038/nrc1754 16341085
8. Dunning AM Dowsett M Healey CS Tee L Luben RN Folkerd E Novik KL Kelemen L Ogata S Pharoah PD et al Polymorphisms associated with circulating sex hormone levels in postmenopausal women J Natl Cancer Inst 2004, 96(12):936-945 15199113
9. Haiman CA Dossus L Setiawan VW Stram DO Dunning AM Thomas G Thun MJ Albanes D Altshuler D Ardanaz E et al Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women Cancer Res 2007, 67(5):1893-1897 10.1158/ 0008-5472.CAN-06-4123 17325027
10. Heldring N Pike A Andersson S Matthews J Cheng G Hartman J Tujague M Strom A Treuter E Warner M et al Estrogen receptors: How do they signal and what are their targets Physiol Rev 2007, 87(3):905-931 10.1152/ physrev.00026.2006 17615392
11. Jordan VC O'Malley BW Selective estrogen-receptor modulators and antihormonal resistance in breast cancer J Clin Oncol 2007, 25(36):5815-5824 10.1200/JCO.2007.11.3886 17893378
12. Shang Y Brown M Molecular determinants for the tissue specificity of SERMs Science 2002, 295(5564):2465-2468 10.1126/science.1068537 11923541
13. Smith CL O'Malley BW Coregulator function: A key to understanding tissue specificity of selective receptor modulators Endocr Rev 2004, 25(1):45-71 10.1210/er.2003-0023 14769827
14. Kolonel LN Henderson BE Hankin JH Nomura AM Wilkens LR Pike MC Stram DO Monroe KR Earle ME Nagamine FS A multiethnic cohort in Hawaii and Los Angeles: Baseline characteristics Am J Epidemiol 2000, 151(4):346-357 10695593
15. Haiman CA Stram DO Cheng I Giorgi EE Pooler L Penney K Le Marchand L Henderson BE Freedman ML Common genetic variation at PTEN and risk of sporadic breast and prostate cancer Cancer Epidemiol Biomarkers Prev 2006, 15(5):1021-1025 10.1158/1055-9965.EPI-05-0896 16702386
16. Lee SA Haiman CA Burtt NP Pooler LC Cheng I Kolonel LN Pike MC Altshuler D Hirschhorn JN Henderson BE et al A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: The multiethnic cohort BMC Med Genet 2007, 8:72 2219987 18053149 10.1186/ 1471-2350-8-72
17. Setiawan VW Cheng I Stram DO Giorgi E Pike MC Berg Van Den D Pooler L Burtt NP Le Marchand L Altshuler D et al A systematic assessment of common genetic variation in CYP11A and risk of breast cancer Cancer Res 2006, 66(24):12019-12025 10.1158/0008-5472.CAN-06-1101 17178901
18. Dean FB Hosono S Fang L Wu X Faruqi AF Bray-Ward P Sun Z Zong Q Du Y Du J et al Comprehensive human genome amplification using multiple displacement amplification Proc Natl Acad Sci USA 2002, 99(8):5261-5266 122757 11959976 10.1073/pnas.082089499
19. Paez JG Lin M Beroukhim R Lee JC Zhao X Richter DJ Gabriel S Herman P Sasaki H Altshuler D et al Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification Nucleic Acids Res 2004, 32(9):e71 419624 15150323 10.1093/ nar/gnh069
20. Ewing B Hillier L Wendl MC Green P Base-calling of automated sequencer traces using phred. I. Accuracy assessment Genome Res 1998, 8(3):175-185 9521921
21. Gordon D Abajian C Green P Consed: A graphical tool for sequence finishing Genome Res 1998, 8(3):195-202 9521923
22. Nickerson DA Tobe VO Taylor SL PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing Nucleic Acids Res 1997, 25(14):2745-2751 146817 9207020 10.1093/nar/25.14.2745
23. Ewing B Green P Base-calling of automated sequencer traces using phred. II. Error probabilities Genome Res 1998, 8(3):186-194 9521922
24. Livak KJ Allelic discrimination using fluorogenic probes and the 5′ nuclease assay Genet Anal 1999, 14(5-6):143-149 10084106
25. Wigginton JE Cutler DJ Abecasis GR A note on exact tests of Hardy-Weinberg equilibrium Am J Hum Genet 2005, 76(5):887-893 1199378 15789306 10.1086/429864
26. Betticher DC Thatcher N Altermatt HJ Hoban P Ryder WD Heighway J Alternate splicing produces a novel cyclin D1 transcript Oncogene 1995, 11(5):1005-1011 7675441
27. Shirazi SK Bober MA Coetzee GA Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene) Clin Genet 1998, 54(1):102-103 9727751
28. Shink E Harvey M Tremblay M Raymond C Labbe M Gagne B Barden N Exclusion of non-synonymous SNPs and a polyglutamine tract in SMRT/N-CoR2 as common deleterious mutation for bipolar disorder in the Sagnenay-Lac-St-Jean population Am J Med Genet B Neuropsychiatr Genet 2005, 134B(1):10-12 10.1002/ajmg.b.30145 15635693
29. Pandey N Mittal U Srivastava AK Mukerji M SMARCA2 and THAP11: Potential candidates for polyglutamine disorders as evidenced from polymorphism and protein-folding simulation studies J Hum Genet 2004, 49(11):596-602 10.1007/s10038-004-0194-8 15368101
30. Turnbull C Rahman N Genetic Predisposition to Breast Cancer: Past, Present, and Future Annu Rev Genomics Hum Genet 2008 18544032
31. Easton DF Pooley KA Dunning AM Pharoah PD Thompson D Ballinger DG Struewing JP Morrison J Field H Luben R et al Genome-wide association study identifies novel breast cancer susceptibility loci Nature 2007, 447(7148):1087-1093 10.1038/nature05887 17529967
32. Hunter DJ Kraft P Jacobs KB Cox DG Yeager M Hankinson SE Wacholder S Wang Z Welch R Hutchinson A et al A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer Nat Genet 2007, 39(7):870-874 10.1038/ ng2075 17529973
33. Stacey SN Manolescu A Sulem P Rafnar T Gudmundsson J Gudjonsson SA Masson G Jakobsdottir M Thorlacius S Helgason A et al Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer Nat Genet 2007, 39(7):865-869 10.1038/ ng2064 17529974
34. Stacey SN Manolescu A Sulem P Thorlacius S Gudjonsson SA Jonsson GF Jakobsdottir M Bergthorsson JT Gudmundsson J Aben KK et al Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer Nat Genet 2008, 40(6):703-706 10.1038/ ng.131 18438407
35. Rahman N Seal S Thompson D Kelly P Renwick A Elliott A Reid S Spanova K Barfoot R Chagtai T et al PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 2007, 39(2):165-167 10.1038/ng1959 17200668
36. Seal S Thompson D Renwick A Elliott A Kelly P Barfoot R Chagtai T Jayatilake H Ahmed M Spanova K et al Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nat Genet 2006, 38(11):1239-1241 10.1038/ng1902 17033622
37. Cohen JC Kiss RS Pertsemlidis A Marcel YL McPherson R Hobbs HH Multiple rare alleles contribute to low plasma levels of HDL cholesterol Science 2004, 305(5685):869-872 10.1126/science.1099870 15297675
38. Fearnhead NS Wilding JL Winney B Tonks S Bartlett S Bicknell DC Tomlinson IP Mortensen NJ Bodmer WF Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas Proc Natl Acad Sci USA 2004, 101(45):15992-15997 528777 15520370 10.1073/pnas.0407187101
39. Burwinkel B Wirtenberger M Klaes R Schmutzler RK Grzybowska E Forsti A Frank B Bermejo JL Bugert P Wappenschmidt B et al Association of NCOA3 polymorphisms with breast cancer risk Clin Cancer Res 2005, 11(6):2169-2174 10.1158/1078-0432.CCR-04-1621 15788663
40. Wirtenberger M Tchatchou S Hemminki K Schmutzhard J Sutter C Schmutzler RK Meindl A Wappenschmidt B Kiechle M Arnold N Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer Carcinogenesis 2006, 27(11):2201-2208 10.1093/carcin/bgl067 16704985
41. Ceschi M Sun CL Berg Van Den D Koh WP Yu MC Probst-Hensch N The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore Carcinogenesis 2005, 26(8):1457-1464 10.1093/carcin/bgi093 15845652
42. Onay UV Aaltonen K Briollais L Knight JA Pabalan N Kilpivaara O Andrulis IL Blomqvist C Nevanlinna H Ozcelik H Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk BMC Cancer 2008, 8:6 2254632 18194538 10.1186/1471-2407-8-6
43. Yu CP Yu JC Sun CA Tzao C Ho JY Yen AM Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1 Breast Cancer Res Treat 2008, 107(1):95 -02 10.1007/ s10549-007-9522-y 18043898
44. Driver KE Song H Lesueur F Ahmed S Barbosa-Morais NL Tyrer JP Ponder BA Easton DF Pharoah PD Dunning AM Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population Carcinogenesis 2008, 29(2):333-341 2346546 18174243 10.1093/ carcin/bgm284
45. Krippl P Langsenlehner U Renner W Yazdani-Biuki B Wolf G Wascher TC Paulweber B Weitzer W Leithner A Samonigg H The 870G > A polymorphism of the cyclin D1 gene is not associated with breast cancer Breast Cancer Res Treat 2003, 82(3):165-168 10.1023/B:BREA.0000004372.20461.33 14703063
46. Shu XO Moore DB Cai Q Cheng J Wen W Pierce L Cai H Gao YT Zheng W Association of cyclin D1 genotype with breast cancer risk and survival Cancer Epidemiol Biomarkers Prev 2005, 14(1):91-97 15668481
47. Cox A Dunning AM Garcia-Closas M Balasubramanian S Reed MW Pooley KA Scollen S Baynes C Ponder BA Chanock S et al A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 2007, 39(3):352-358 10.1038/ng1981 17293864
48. Haiman CA Hankinson SE Spiegelman D Colditz GA Willett WC Speizer FE Brown M Hunter DJ Polymorphic repeat in AIB1 does not alter breast cancer risk Breast Cancer Res 2000, 2(5):378-385 13920 11056690 10.1186/ bcr82
49. Montgomery KG Chang JH Gertig DM Dite GS McCredie MR Giles GG Southey MC Hopper JL Campbell IG The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women Breast Cancer Res 2005, 7(3):R353-356 1143559 15987430 10.1186/ bcr1009
50. Rebbeck TR Wang Y Kantoff PW Krithivas K Neuhausen SL Godwin AK Daly MB Narod SA Brunet JS Vesprini D et al Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history Cancer Res 2001, 61(14):5420-5424 11454686
51. Spurdle AB Antoniou AC Kelemen L Holland H Peock S Cook MR Smith PL Greene MH Simard J Plourde M et al The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers Cancer Epidemiol Biomarkers Prev 2006, 15(1):76-79 10.1158/ 1055-9965.EPI-05-0709 16434590
52. Wilkening S Burwinkel B Grzybowska E Klaes R Pamula J Pekala W Zientek H Hemminki K Forsti A Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer Cancer Epidemiol Biomarkers Prev 2005, 14(1):291-292 15668512